VJHemOnc is committed to improving our service to you

COMy 2019 | Beyond KarMMa-2: agents targeting BCMA in MM

VJHemOnc is committed to improving our service to you

Andrew Yee

Andrew Yee, MD, of Massachusetts General Hospital Cancer Center, Boston, MA, discusses the KarMMa-2 trial (NCT03601078) and further trials that also targeting BCMA. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter